View All Announcements
COVID-19 therapeutics can be used to prevent or treat eligible non-hospitalized patients who have mild to moderate COVID-19 symptoms. Prevention and early treatment for eligible patients can help improve patient outcomes, reduce stress on healthcare facilities, and even save lives.
HHS/ASPR has purchased supplies of COVID-19 therapeutic products and we are working with state and territorial health departments as well as national healthcare and medical organizations and associations to get the treatments into the hands of healthcare providers quickly, with a focus on areas of the country hardest hit by the pandemic.
Federal Response to COVID‑19: Therapeutics Clinical Implementation Guide
Side-by-Side Overview: Outpatient Therapies Authorized for Treatment of Mild-Moderate COVID-19
COVID-19 Therapeutics Decision Aid
Thresholds, Orders, and Replenishment by Jurisdiction
Social Media Digital Toolkit
COVID-19 Therapeutic Product Expiration
View More Information About Previously Available Products
Test to Treat
Information for Long‑Term Care Facilities
Federal Retail Pharmacy Therapeutics Program
COVID-19 Therapeutics Locator for Providers